PYREFIN

Pyrefin is a development-stage pharmaceutical company focused on producing EP2 receptor antagonists. The drugs Pyrefin is testing have myriad potential uses, including treatment for epileptic seizures. Rodent trials have shown efficacy in treatment for seizure-induced brain injury, endometriosis, and osteoarthritis without behavioral or organ toxicity after 30 days. Phase 1A of GRA’s venture development support focused Pyrefin’s team on prioritizing the clinical use of its treatment.
#SimilarOrganizations #People #Financial #More

PYREFIN

Industry:
Biotechnology Life Science Pharmaceutical

Status:
Active

Total Funding:
100.64 K USD


Similar Organizations

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

Current Employees Featured

dennis-mcnamara_image

Dennis McNamara
Dennis McNamara Chief Executive Officer and Co-Founder @ Pyrefin
Chief Executive Officer and Co-Founder
2019-01-01

ray-dingledine_image

Ray Dingledine
Ray Dingledine Co-Founder & Chair of Board of Directors @ Pyrefin
Co-Founder & Chair of Board of Directors
2019-04-01

thota-ganesh_image

Thota Ganesh
Thota Ganesh Co-Founder, Board Member and Secretory @ Pyrefin
Co-Founder, Board Member and Secretory
2019-04-01

Founder


dennis-mcnamara_image

Dennis McNamara

ray-dingledine_image

Ray Dingledine

thota-ganesh_image

Thota Ganesh

Investors List

georgia-research-alliance_image

Georgia Research Alliance

Georgia Research Alliance investment in Grant - Pyrefin

georgia-research-alliance_image

Georgia Research Alliance

Georgia Research Alliance investment in Grant - Pyrefin

More informations about "Pyrefin" on Search Engine

linkstock.net © 2022. All rights reserved